Transgene S.A.
TRGNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $76,402 | $155,016 | $149,574 | $148,589 |
| - Cash | $16,772 | $16,670 | $15,320 | $15,666 |
| + Debt | $31,065 | $10,396 | $90 | $1,349 |
| Enterprise Value | $90,695 | $148,742 | $134,344 | $134,272 |
| Revenue | $4,579 | $284 | $23 | $3,137 |
| % Growth | 1,512.3% | 1,134.8% | -99.3% | – |
| Gross Profit | -$13,331 | $15,707 | -$15,400 | -$10,882 |
| % Margin | -291.1% | 5,530.6% | -66,956.5% | -346.9% |
| EBITDA | -$16,410 | -$8,108 | -$18,544 | -$13,464 |
| % Margin | -358.4% | -2,854.9% | -80,626.1% | -429.2% |
| Net Income | -$19,295 | -$17,486 | -$16,485 | -$6,426 |
| % Margin | -421.4% | -6,157% | -71,673.9% | -204.8% |
| EPS Diluted | -0.15 | -0.18 | -0.16 | -0.063 |
| % Growth | 16.7% | -12.5% | -152.4% | – |
| Operating Cash Flow | -$17,946 | -$5,415 | -$18,133 | -$17,010 |
| Capital Expenditures | -$279 | -$1,071 | -$2,004 | -$1,265 |
| Free Cash Flow | -$18,225 | -$6,486 | -$20,137 | -$18,275 |